Home » GOG 0259: NURSE-DELIVERED WRITE SYMPTOMS VS CARE AS USUAL FOR OPTIMAL SYMPTOM MANAGEMENT FOR WOMEN WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
GOG 0259: NURSE-DELIVERED WRITE SYMPTOMS VS CARE AS USUAL FOR OPTIMAL SYMPTOM MANAGEMENT FOR WOMEN WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
Approval Date: 4/20/2010
Principal Investigator: Jayson Field, MD
This randomized clinical trial is studying two different symptom management programs to see how well they work compared with usual care in patients with recurrent or persistent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
Eligibility:
Each study has its own guidelines for who can participate, called "eligibility criteria", with only the study doctor able to determine if you meet all eligibility criteria. More information can be found at http://clinicaltrials.gov/ct2/show/NCT00958698
Contact Person:
CCTO Royal Oak
248-551-3230
Status of Clinical Trial:
open and enrolling


